What is the 13F Pro Quality Score for ACNT?

13F Pro ranks ASCENT INDUSTRIES CO. (ACNT) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View ACNT's current score at https://13fpro.ai/company/ACNT (free sign-up required for the full ranking).

Where does 13F Pro source ACNT data?

All ASCENT INDUSTRIES CO. fundamentals and ownership data come directly from SEC EDGAR. ASCENT INDUSTRIES CO. files with the SEC under CIK 95953. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is ACNT in?

ASCENT INDUSTRIES CO. (ACNT) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is ACNT research updated on 13F Pro?

ACNT's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

ASCENT INDUSTRIES CO.(ACNT)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaqsmall

Institutional-grade research for retail investors

SEC EDGAR: CIK 95953 ACNT stock profile & AI dashboard →

13F Pro Quality Score

17.0/100

Rank #2,832 of 2,961 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

3.1/100

Profitability

25.6/100

Balance Sheet

24.5/100

Earnings Quality

4.5/100

Free Cash Flow

16.5/100

Institutional Flow

24.2/100

Revenue Scale

13.3/100

Dilution Risk

42.6/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why ACNT Scores 17/100

exact factor attribution · 2026-09-11

ACNT's composite is held back by revenue growth and scale. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Shareholder dilution

-0.4 pts

43th pct

Earnings growth

-0.7 pts

37th pct

Institutional flow

-1.3 pts

24th pct

Capital efficiency

-2.5 pts

25th pct

Profitability

-3.7 pts

26th pct

Earnings quality

-4.5 pts

5th pct

Free cash flow

-5.0 pts

17th pct

Scale

-5.5 pts

13th pct

Revenue growth

-9.4 pts

3th pct

Latest change (2026-08-04): 30 → 27 · ↓ Profit margin 54→38; ↓ Capital efficiency 36→26

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

ACNT Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for ASCENT INDUSTRIES CO. (ACNT), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ACNT at 17.0/100 on a 32-signal composite quality model, placing it at rank #2,832 of 2,961 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (3.1) and earnings quality (4.5), which score below median versus the broader universe. Shareholder dilution risk is elevated at 42.6/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), ASCENT INDUSTRIES CO. reports quarterly revenue of $25.7M, net income of $670.0K, free cash flow of $-3.0M. Top institutional holders of ACNT by reported 13-F value include Mink Brook Asset Management, VANGUARD CAPITAL MANAGEMENT, BARD ASSOCIATES, based on the most recent SEC filings. ACNT trades on the Nasdaq exchange and files with the SEC under CIK 95953. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ACNT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ASCENT INDUSTRIES CO. directly from SEC EDGAR. ASCENT INDUSTRIES CO.'s 13F Pro composite quality score has ranged between 17 and 56 since 2022, currently 17.0 — a declining long-term trajectory across 61 quarterly and live scoring snapshots.

✦

Fun facts about ASCENT INDUSTRIES CO.

Quirks, history, and lore behind ACNT — the kind of stuff that makes a stock memorable.

1
The Basics
A small-cap industrial company listed on Nasdaq, operating across specialty chemicals and tubular products — not glamorous, but the pipes and chemicals have to come from somewhere.
2
The Numbers
Annual revenues in the range of a few hundred million dollars, with the kind of thin margins you'd expect from a company that sells steel tubes — not software.
3
The History
The company traces roots back decades as a diversified specialty manufacturer, before sharpening its focus and eventually rebranding entirely to signal a new strategic direction.
4
The Secret
Its tubular products segment serves energy and industrial customers with stainless steel pipe and tube — the unglamorous backbone of refineries and chemical plants everywhere.
5
The Lore
Formerly known as Synalloy Corporation, it shed that name and reinvented itself — proof that even a company selling steel tubes thinks a fresh brand matters.
6
The Giveaway
Once called Synalloy, now reborn under a name that sounds like a rocket company but actually makes stainless steel tubes and specialty chemicals — ticker: ACNT.

▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q2 2026

$25.7M

Net Income

Q2 2026

$670.0K

Free Cash Flow

Q2 2026

$-3.0M

ROIC

Q2 2026

-1.3%

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

-7.2% YoY

$74.9MFY 2025

FY22 $262.0MFY23 $193.2MFY24 $80.8MFY25 $74.9M

Net Income

+106.4% YoY

$867.0KFY 2025

FY22 $22.1MFY23 $-26.6MFY24 $-13.6MFY25 $867.0K

Operating Income

+34.9% YoY

$-7.0MFY 2025

FY22 $14.5MFY23 $-37.4MFY24 $-10.8MFY25 $-7.0M

EPS (Diluted)

+106.7% YoY

$0.09FY 2025

FY22 $2.12FY23 $-2.63FY24 $-1.35FY25 $0.09

Total Assets

-24.0% YoY

$111.9MFY 2025

FY22 $269.0MFY23 $163.3MFY24 $147.3MFY25 $111.9M

Total Debt

—FY 2025

FY22 $74.0MFY23 $0.00FY24 $0.00FY25 —

Op. Cash Flow

-103.5% YoY

$-519.0KFY 2025

FY22 $5.6MFY23 $23.1MFY24 $14.7MFY25 $-519.0K

Free Cash Flow

-115.2% YoY

$-2.1MFY 2025

FY22 $2.2MFY23 $20.2MFY24 $13.6MFY25 $-2.1M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$74.9M -7.2%	$80.8M -58.2%	$193.2M -26.3%	$262.0M -21.7%	$334.7M +30.7%	$256.0M
Net Income	$867.0K +106.4%	$-13.6M +48.9%	$-26.6M -220.7%	$22.1M +9.0%	$20.2M +174.2%	$-27.3M
Operating Income	$-7.0M +34.9%	$-10.8M +71.1%	$-37.4M -357.4%	$14.5M -46.8%	$27.3M +188.0%	$-31.1M
EPS (Diluted)	$0.09 +106.7%	$-1.35 +48.7%	$-2.63 -224.1%	$2.12 -0.9%	$2.14 +171.8%	$-2.98
Total Assets	$111.9M -24.0%	$147.3M -9.8%	$163.3M -39.3%	$269.0M +1.1%	$266.0M +28.5%	$207.0M
Total Debt	—	$0.00	$0.00 -100.0%	$74.0M +1.6%	$72.9M +17.0%	$62.2M
Operating Cash Flow	$-519.0K -103.5%	$14.7M -36.4%	$23.1M +313.8%	$5.6M -70.7%	$19.1M +6.0%	$18.0M
Free Cash Flow	$-2.1M -115.2%	$13.6M -32.8%	$20.2M +825.0%	$2.2M -87.6%	$17.6M +23.4%	$14.2M

Get alerted when ACNT's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for ASCENT INDUSTRIES CO. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of ACNT

Mink Brook Asset Management LLC
$13.3M884,483 sh
VANGUARD CAPITAL MANAGEMENT LLC
$5.2M345,062 sh
BARD ASSOCIATES INC
$4.8M321,984 sh
DIMENSIONAL FUND ADVISORS LP
$4.3M283,567 sh
RENAISSANCE TECHNOLOGIES LLC
$4.2M279,202 sh
Oppenheimer & Close, LLC
$3.5M233,093 sh
WELLS FARGO & COMPANY/MN
$3.1M203,068 sh
HEARTLAND ADVISORS INC
$3.0M200,618 sh
De Lisle Partners LLP
$3.0M197,824 sh
AMERICAN CENTURY COMPANIES INC
$2.9M190,587 sh

Fund	Value	Shares
Mink Brook Asset Management LLC	$13.3M	884,483
VANGUARD CAPITAL MANAGEMENT LLC	$5.2M	345,062
BARD ASSOCIATES INC	$4.8M	321,984
DIMENSIONAL FUND ADVISORS LP	$4.3M	283,567
RENAISSANCE TECHNOLOGIES LLC	$4.2M	279,202
Oppenheimer & Close, LLC	$3.5M	233,093
WELLS FARGO & COMPANY/MN	$3.1M	203,068
HEARTLAND ADVISORS INC	$3.0M	200,618
De Lisle Partners LLP	$3.0M	197,824
AMERICAN CENTURY COMPANIES INC	$2.9M	190,587

Companies Similar to ACNT

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

ASRT

Assertio Holdings, Inc.

AI score

Very similar · 1 shared holders

PERRITT CAPITAL MANAGEMENT INC

XTNT

Xtant Medical Holdings, Inc.

AI score

Similar quality profile · 1 shared holders

Mink Brook Asset Management LLC

SRTS

Sensus Healthcare, Inc.

AI score

Similar quality profile · 1 shared holders

PERRITT CAPITAL MANAGEMENT INC

IRIX

IRIDEX CORP

AI score

Similar quality profile · 1 shared holders

AMH Equity Ltd

FTLF

FITLIFE BRANDS, INC.

AI score

Shared smart-money ownership · 2 shared holders

Mink Brook Asset Management LLC BARD ASSOCIATES INC

NAII

NATURAL ALTERNATIVES INTERNATIONAL INC

AI score

Similar quality profile · 1 shared holders

Mink Brook Asset Management LLC

SIGA

SIGA TECHNOLOGIES INC

AI score

Similar quality profile · 1 shared holders

R Squared Ltd

ANIK

Anika Therapeutics, Inc.

AI score

Similar quality profile · 2 shared holders

R Squared Ltd OCCUDO QUANTITATIVE STRATEGIES LP

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put ACNT on your watchlist

Track score changes the day ASCENT INDUSTRIES CO. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is ACNT a good stock to buy?

13F Pro's AI-powered analysis of ASCENT INDUSTRIES CO. (ACNT) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ACNT are available on the ACNT stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. ACNT is classified as a small company.

Which hedge funds own ACNT?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ACNT. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of ASCENT INDUSTRIES CO.'s investment landscape.